mutLBSgeneDB

mutLBSgeneDB
mutated Ligand Binding Site gene DataBase

Home

Download

 Statistics

Help

About Us

Bioinformatics and Systems Medicine Laboratory Bioinformatics and Systems Medicine Laboratory

Gene Summary

Ligand Binding Site Mutation Information

Protein Structure Related Information

Gene Expression and Gene-Gene Network

Phenotype Information

Pharmacological Information

Conservation Information for LBS

Gene summary for PHKG2
Gene summary
Basic gene Info.Gene symbolPHKG2
Gene namephosphorylase kinase, gamma 2 (testis)
SynonymsGSD9C
CytomapUCSC genome browser: 16p11.2
Type of geneprotein-coding
RefGenesNM_000294.2,
NM_001172432.1,
DescriptionPHK-gamma-LTPHK-gamma-TPSK-C3Phosphorylase kinase, gamma 2 (testis/liver)phosphorylase b kinase gamma catalytic chain, liver/testis isoformphosphorylase b kinase gamma catalytic chain, testis/liver isoformphosphorylase kinase subunit gamma-2serine/
Modification date20141222
dbXrefs MIM : 172471
HGNC : HGNC
Ensembl : ENSG00000156873
HPRD : 01405
Vega : OTTHUMG00000132400
ProteinUniProt: P15735
go to UniProt's Cross Reference DB Table
ExpressionCleanEX: HS_PHKG2
BioGPS: 5261
PathwayNCI Pathway Interaction Database: PHKG2
KEGG: PHKG2
REACTOME: PHKG2
Pathway Commons: PHKG2
ContextiHOP: PHKG2
ligand binding site mutation search in PubMed: PHKG2
UCL Cancer Institute: PHKG2
Assigned class in mutLBSgeneDBB: This gene belongs to targetable_mutLBSgenes.

Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez
GO IDGO TermPubMed ID


Top
Ligand binding site mutations for PHKG2
Lollipop-style diagram of mutations at LBS in amino-acid sequence.
We represented ligand binding site mutations only. (You can see big image via clicking.)
 
: non-synonymous mutation on LBS, Circle size denotes number of samples.

Cancer type specific mutLBS sorted by frequency
LBSAAchange of nsSNVCancer type# samples
G113E114KBLCA1
A51A51TSTAD1
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma.


Top
Protein structure related information for PHKG2
Relative protein structure stability change (ΔΔE) using Mupro 1.1
Mupro score denotes assessment of the effect of mutations on thermodynamic stability.
  (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability)
: nsSNV at non-LBS: nsSNV at LBS

nsSNVs sorted by the relative stability change of protein structure by each mutation
Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene.
LBSAAchange of nsSNVRelative stability change
G113E114K-1.4975966
A51A51T-1.0837233
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132)

Structure image for PHKG2 from PDB

Top
Differential gene expression and gene-gene network for PHKG2
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types

Differential co-expressed gene network based on protein-protein interaction data (CePIN)
* Left PPI network was created from samples with mutations in the LBS of PHKG2 and the right PPI network was created from samples without mutations in the LBS of PHKG2. Only genes with p-value < 0.05 are shown.
Red circle: input gene. Orange circle: LBSgene. Blue circle: other gene.


Top

Top
Phenotype information for PHKG2
Gene level disease information (DisGeNet)
Disease IDDisease name# PubMedAssociation type
umls:C2751643Glycogen Storage Disease IXC2Biomarker, GeneticVariation

Mutation level pathogenic information (ClinVar annotation)
Allele IDAA changeClinical significanceOriginPhenotype IDs

Top
Pharmacological information for PHKG2
Gene expression profile of anticancer drug treated cell-lines (CCLE)
Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient.

Gene-centered drug-gene interaction network
Drug information targeting mutLBSgene (Approved drugs only)
Drug statusDrugBank IDNameTypeDrug structure

Gene-centered ligand-gene interaction network

Ligands binding to mutated ligand binding site of PHKG2 go to BioLip
Ligand IDLigand short nameLigand long namePDB IDPDB namemutLBS
B49SUNITINIB2y7jAA51 G113
B49SUNITINIB2y7jBA51 G113
B49SUNITINIB2y7jCA51 G113
B49SUNITINIB2y7jDA51 G113


Top
Conservation information for LBS of PHKG2
Multiple alignments for P15735 in multiple species
LBSAA sequence# speciesSpecies
A51TGHEFAVKIME1Homo sapiens
A51TGDEFAVKIME1Mus musculus
A51TGQEFAVKIME1Bos taurus
D108MFLVFDLMRKG3Homo sapiens, Mus musculus, Bos taurus
D117KGELFDYLTEK3Homo sapiens, Mus musculus, Bos taurus
D171QIRLSDFGFSC3Homo sapiens, Mus musculus, Bos taurus
F107FMFLVFDLMRK3Homo sapiens, Mus musculus, Bos taurus
G113DLMRKGELFDY3Homo sapiens, Mus musculus, Bos taurus
G31PKDVIGRGVSS2Homo sapiens, Bos taurus
G31PKDIIGRGVSS1Mus musculus
I30DPKDVIGRGVS2Homo sapiens, Bos taurus
I30DPKDIIGRGVS1Mus musculus
I91GHPHIITLIDS3Homo sapiens, Mus musculus, Bos taurus
L109FLVFDLMRKGE3Homo sapiens, Mus musculus, Bos taurus
L160KPENILLDDNM3Homo sapiens, Mus musculus, Bos taurus
M110LVFDLMRKGEL3Homo sapiens, Mus musculus, Bos taurus
R111VFDLMRKGELF3Homo sapiens, Mus musculus, Bos taurus
R32KDVIGRGVSSV2Homo sapiens, Bos taurus
R32KDIIGRGVSSV1Mus musculus
V29YDPKDVIGRGV2Homo sapiens, Bos taurus
V29YDPKDIIGRGV1Mus musculus


Copyright © 2016-Present - The University of Texas Health Science Center at Houston
Site Policies | State of Texas